← Back
Data updated: Mar 29, 2026
ACS DOBFAR SPA
Infectious DiseaseDermatologyGastroenterology
Generics
ACS DOBFAR SPA is a generic drug manufacturer focused on Infectious Disease, Dermatology, Gastroenterology.
1997
Since
6
Drugs
-
Trials
36
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 50%
2 drugs
Dermatology 25%
1 drugs
Gastroenterology 25%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Dermatology
CASPER PHARMA LLC big-pharma
Infectious Disease, Gastroenterology, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology
Active (2)
Discontinued (4)
Company Info
- First Approval
- 1997-05-30
- Latest
- 2025-10-01
- Applications
- 9